416 related articles for article (PubMed ID: 12688297)
1. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
3. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
4. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
5. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
Torres MA
Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
[No Abstract] [Full Text] [Related]
6. International intellectual property, access to health care, and human rights: South Africa v. United States.
Nagan WP
Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137
[No Abstract] [Full Text] [Related]
7. Simplifying HIV therapeutics, and the global treatment of AIDS.
Laurence J
AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
[No Abstract] [Full Text] [Related]
8. An unequal activism for an unequal epidemic?
Selemogo M
Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
[TBL] [Abstract][Full Text] [Related]
9. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
10. Inequalities in health: access to treatment for HIV/AIDS.
Giuliano M; Vella S
Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
[TBL] [Abstract][Full Text] [Related]
11. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
Viana JM
Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
[No Abstract] [Full Text] [Related]
12. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
13. Rights, patents, markets and the global AIDS pandemic.
Gathii JT
Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
[No Abstract] [Full Text] [Related]
14. Access to essential medicines: a Hobbesian social contract approach.
Ashcroft RE
Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
[TBL] [Abstract][Full Text] [Related]
15. Providing antiretroviral therapy for HIV infection.
Steinbrook R
N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
[No Abstract] [Full Text] [Related]
16. Antiretrovirals in India.
Pujari S
Issues Med Ethics; 1998 Jan; 6(1):24-5. PubMed ID: 16267924
[No Abstract] [Full Text] [Related]
17. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
18. Balancing effectiveness and access to HIV treatment in the developing world.
Hill A; Wood E
AIDS; 2007 Jan; 21(3):361-3. PubMed ID: 17255743
[No Abstract] [Full Text] [Related]
19. Medicines for all, not just the rich.
Davey S
Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220
[No Abstract] [Full Text] [Related]
20. Commentary: the reality of treating HIV and AIDS in poor countries.
Sykes R
BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
